Found: 6
Select item for more details and to access through your institution.
Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI.
- Published in:
- European Radiology, 2024, v. 34, n. 5, p. 3087, doi. 10.1007/s00330-023-10215-z
- By:
- Publication type:
- Article
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26940-2
- By:
- Publication type:
- Article
Systemic Adoptive-Cell-Transfer Immunotherapy for High-Grade Meningiomas Targeting NYESO-1 Using TCR-transduced T-Cells.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 5, p. 78, doi. 10.3171/2022.5.JNS.AANS2022abstracts
- By:
- Publication type:
- Article
ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi6, doi. 10.1093/neuonc/noy148.020
- By:
- Publication type:
- Article
IMMU-37. VEMURAFENIB ENHANCES THE CYTOTOXICITY OF NY-ESO-1 TCR ENGINEERED T-CELLS FOR BRAF MUTANT BRAIN TUMORS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi129, doi. 10.1093/neuonc/noy148.540
- By:
- Publication type:
- Article
Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 796, doi. 10.1093/neuonc/now287
- By:
- Publication type:
- Article